ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998

November issue of Business & Regulatory Report included.

November 28, 2003

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects

November 26, 1999